SG11201809687TA - Pyridinyl derivatives, pharmaceutical compositions and uses thereof as aoc3 inhibitors - Google Patents

Pyridinyl derivatives, pharmaceutical compositions and uses thereof as aoc3 inhibitors

Info

Publication number: SG11201809687TA
Authority: SG; Singapore
Prior art keywords: rhein; international; gmbh; ingelheim; boehringer ingelheim
Prior art date: 2016-05-12

Application number

SG11201809687TA

Other languages

English (en)

Inventor

Andreas Blum

Cédrickx Godbout

Joerg Hehn

Stefan Peters

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-05-12

Filing date

2017-05-08

Publication date

2018-11-29

2017-05-08 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2018-11-29 Publication of SG11201809687TA publication Critical patent/SG11201809687TA/en

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 3
239000003112 inhibitor Substances 0.000 title abstract 2
125000004076 pyridyl group Chemical group 0.000 title abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
101000694615 Homo sapiens Membrane primary amine oxidase Proteins 0.000 abstract 1
102100027159 Membrane primary amine oxidase Human genes 0.000 abstract 1
FIULGFJIHJJXMT-UHFFFAOYSA-N [C]1[N]C=CC=C1 Chemical class [C]1[N]C=CC=C1 FIULGFJIHJJXMT-UHFFFAOYSA-N 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000008520 organization Effects 0.000 abstract 1
102220240796 rs553605556 Human genes 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

SG11201809687TA 2016-05-12 2017-05-08 Pyridinyl derivatives, pharmaceutical compositions and uses thereof as aoc3 inhibitors SG11201809687TA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP16169356		2016-05-12
PCT/EP2017/060890 WO2017194453A1 (fr)	2016-05-12	2017-05-08	Dérivés de pyridinyle, compositions pharmaceutiques et utilisations de ceux-ci en tant qu'inhibiteurs d'aoc3

Publications (1)

Publication Number	Publication Date
SG11201809687TA true SG11201809687TA (en)	2018-11-29

Family

ID=55967162

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11201809687TA SG11201809687TA (en)	2016-05-12	2017-05-08	Pyridinyl derivatives, pharmaceutical compositions and uses thereof as aoc3 inhibitors

Country Status (32)

Country	Link
US (1)	US9926292B2 (fr)
EP (1)	EP3455216B1 (fr)
JP (1)	JP6639702B2 (fr)
KR (1)	KR20190003995A (fr)
CN (1)	CN109153664B (fr)
AR (1)	AR108462A1 (fr)
AU (1)	AU2017262707B2 (fr)
CA (1)	CA3023805A1 (fr)
CL (1)	CL2018003158A1 (fr)
CO (1)	CO2018012020A2 (fr)
CY (1)	CY1123744T1 (fr)
DK (1)	DK3455216T3 (fr)
EA (1)	EA037188B1 (fr)
ES (1)	ES2844926T3 (fr)
HR (1)	HRP20202078T1 (fr)
HU (1)	HUE053312T2 (fr)
IL (1)	IL262662B (fr)
JO (1)	JOP20170115B1 (fr)
LT (1)	LT3455216T (fr)
MA (1)	MA44965B1 (fr)
MX (1)	MX379327B (fr)
PE (1)	PE20190151A1 (fr)
PH (1)	PH12018502376B1 (fr)
PL (1)	PL3455216T3 (fr)
PT (1)	PT3455216T (fr)
RS (1)	RS61256B1 (fr)
SA (1)	SA518400393B1 (fr)
SG (1)	SG11201809687TA (fr)
SI (1)	SI3455216T1 (fr)
TW (1)	TWI746551B (fr)
UA (1)	UA121930C2 (fr)
WO (1)	WO2017194453A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20210113561A1 (en) *	2018-04-17	2021-04-22	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
CN112789277B (zh) *	2018-10-22	2022-11-04	广东东阳光药业有限公司	胍类衍生物及其用途
JP7425793B2 (ja)	2018-10-29	2024-01-31	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ピリジニルスルホンアミド誘導体、医薬組成物およびそれらの使用
CA3112510A1 (fr) *	2018-10-29	2020-05-07	Boehringer Ingelheim International Gmbh	Derives de pyridinyl sulfonamide, compositions pharmaceutiques et leurs utilisations
MX2022005199A (es)	2019-10-29	2022-08-04	Eccogene Shanghai Co Ltd	Inhibidores de ssao y uso de los mismos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19518073A1 (de) *	1995-05-17	1996-11-21	Hoechst Ag	Substituierte Benzyloxycarbonylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
WO2005020921A2 (fr) *	2003-08-29	2005-03-10	Exelixis, Inc.	Modulateurs c-kit et leurs procedes d'utilisation
DE602005013793D1 (de) *	2004-07-27	2009-05-20	Astellas Pharma Inc	Thiazolderivate mit vap-1-hemmender wirkung
EP2479165B1 (fr) *	2009-09-16	2017-10-25	Astellas Pharma Inc.	Composé de glycine
KR101879011B1 (ko) *	2011-03-15	2018-07-16	아스테라스 세이야쿠 가부시키가이샤	구아니딘 화합물
EP3333163A4 (fr)	2015-08-06	2019-01-09	UBE Industries, Ltd.	Dérivé de guanidine substitué

2017
- 2017-05-08 SI SI201730584T patent/SI3455216T1/sl unknown
- 2017-05-08 DK DK17721706.4T patent/DK3455216T3/da active
- 2017-05-08 WO PCT/EP2017/060890 patent/WO2017194453A1/fr not_active Ceased
- 2017-05-08 EP EP17721706.4A patent/EP3455216B1/fr active Active
- 2017-05-08 EA EA201892539A patent/EA037188B1/ru not_active IP Right Cessation
- 2017-05-08 LT LTEP17721706.4T patent/LT3455216T/lt unknown
- 2017-05-08 HU HUE17721706A patent/HUE053312T2/hu unknown
- 2017-05-08 RS RS20201583A patent/RS61256B1/sr unknown
- 2017-05-08 CN CN201780027576.9A patent/CN109153664B/zh active Active
- 2017-05-08 PL PL17721706T patent/PL3455216T3/pl unknown
- 2017-05-08 US US15/588,739 patent/US9926292B2/en active Active
- 2017-05-08 PT PT177217064T patent/PT3455216T/pt unknown
- 2017-05-08 MA MA44965A patent/MA44965B1/fr unknown
- 2017-05-08 AU AU2017262707A patent/AU2017262707B2/en not_active Ceased
- 2017-05-08 HR HRP20202078TT patent/HRP20202078T1/hr unknown
- 2017-05-08 CA CA3023805A patent/CA3023805A1/fr active Pending
- 2017-05-08 UA UAA201812102A patent/UA121930C2/uk unknown
- 2017-05-08 PE PE2018002340A patent/PE20190151A1/es unknown
- 2017-05-08 KR KR1020187035976A patent/KR20190003995A/ko not_active Abandoned
- 2017-05-08 JP JP2018559351A patent/JP6639702B2/ja active Active
- 2017-05-08 SG SG11201809687TA patent/SG11201809687TA/en unknown
- 2017-05-08 ES ES17721706T patent/ES2844926T3/es active Active
- 2017-05-08 MX MX2018013701A patent/MX379327B/es unknown
- 2017-05-11 JO JOP/2017/0115A patent/JOP20170115B1/ar active
- 2017-05-11 AR ARP170101262A patent/AR108462A1/es not_active Application Discontinuation
- 2017-05-11 TW TW106115558A patent/TWI746551B/zh not_active IP Right Cessation
2018
- 2018-10-29 IL IL262662A patent/IL262662B/en unknown
- 2018-11-06 CO CONC2018/0012020A patent/CO2018012020A2/es unknown
- 2018-11-07 SA SA518400393A patent/SA518400393B1/ar unknown
- 2018-11-08 CL CL2018003158A patent/CL2018003158A1/es unknown
- 2018-11-12 PH PH12018502376A patent/PH12018502376B1/en unknown
2021
- 2021-01-19 CY CY20211100039T patent/CY1123744T1/el unknown

Also Published As

Publication number	Publication date
HUE053312T2 (hu)	2021-07-28
AU2017262707B2 (en)	2020-11-19
CN109153664A (zh)	2019-01-04
CO2018012020A2 (es)	2018-11-13
MA44965A (fr)	2019-03-20
RS61256B1 (sr)	2021-01-29
WO2017194453A1 (fr)	2017-11-16
LT3455216T (lt)	2021-01-11
EA201892539A1 (ru)	2019-06-28
SA518400393B1 (ar)	2021-09-08
TWI746551B (zh)	2021-11-21
HRP20202078T1 (hr)	2021-02-19
DK3455216T3 (da)	2021-01-18
JOP20170115B1 (ar)	2021-08-17
UA121930C2 (uk)	2020-08-10
US20170327483A1 (en)	2017-11-16
EP3455216A1 (fr)	2019-03-20
MX379327B (es)	2025-03-11
CY1123744T1 (el)	2022-05-27
JP2019519495A (ja)	2019-07-11
TW201805278A (zh)	2018-02-16
MA44965B1 (fr)	2021-02-26
CN109153664B (zh)	2021-07-16
EA037188B1 (ru)	2021-02-17
CA3023805A1 (fr)	2017-11-16
PL3455216T3 (pl)	2021-05-17
PH12018502376B1 (en)	2021-10-06
MX2018013701A (es)	2019-05-02
SI3455216T1 (sl)	2021-02-26
PT3455216T (pt)	2021-01-18
PH12018502376A1 (en)	2019-04-08
ES2844926T3 (es)	2021-07-23
IL262662A (en)	2018-12-31
CL2018003158A1 (es)	2019-01-18
JP6639702B2 (ja)	2020-02-05
NZ746586A (en)	2021-08-27
AU2017262707A1 (en)	2018-10-11
KR20190003995A (ko)	2019-01-10
PE20190151A1 (es)	2019-01-22
EP3455216B1 (fr)	2020-11-04
AR108462A1 (es)	2018-08-22
US9926292B2 (en)	2018-03-27
IL262662B (en)	2021-07-29

Publication	Publication Date	Title
SG11201900633XA (en)	2019-02-27	Piperidine cxcr7 receptor modulators
SG11201907604UA (en)	2019-09-27	Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
SG11201806863WA (en)	2018-09-27	Tetracyclic pyridone compounds as antivirals
SG11201805940QA (en)	2018-08-30	Benzopyrazole compounds and analogues thereof
SG11201805570WA (en)	2018-07-30	Systems and methods for long term transdermal administration
SG11201907804QA (en)	2019-09-27	Pharmaceutical composition comprising selexipag
SG11201901063SA (en)	2019-03-28	Therapeutic agents for neurodegenerative diseases
SG11201803627XA (en)	2018-06-28	N-substituted indole derivatives as pge2 receptor modulators
SG11201810628XA (en)	2018-12-28	Nasal pharmaceutical compositions with a porous excipient
SG11201407580YA (en)	2014-12-30	Composition comprising two antibodies engineered to have reduced and increased effector function
SG11201901534VA (en)	2019-03-28	Combination therapy with controlled-release cnp agonists
SG11201406973PA (en)	2014-12-30	Complement pathway modulators and uses thereof
SG11201806750WA (en)	2018-09-27	Substituted 1,2,3-triazoles as nr2b-selective nmda modulators
SG11201808237UA (en)	2018-10-30	Substituted indole compound derivatives as dengue viral replication inhibitors
SG11201908465QA (en)	2019-10-30	Substituted indoline derivatives as dengue viral replication inhibitors
SG11201807597UA (en)	2018-10-30	Methods of treating depression using orexin-2 receptor antagonists
SG11201906436VA (en)	2019-08-27	Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201808566WA (en)	2018-11-29	Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide
SG11201811804QA (en)	2019-01-30	Oxadiazolopyridine derivates for use as ghrelin o-acyl transferase (goat) inhibitors
SG11201407988UA (en)	2015-01-29	Process for improved opioid synthesis
SG11201900546UA (en)	2019-02-27	Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
SG11201809882XA (en)	2018-12-28	Pharmaceutical combinations for treating cancer
SG11201901850XA (en)	2019-04-29	Dopamine-b-hydroxylase inhibitors
SG11201901249YA (en)	2019-04-29	Aza-indazole compounds for use in tendon and/or ligament injuries
SG11201901048VA (en)	2019-03-28	Pharmaceutical compositions and uses directed to lysosomal storage disorders